3 Firms Face Off For Lead Counsel Spot In Blood Drug Suit

By Aaron West · March 8, 2023, 4:05 PM EST

It's a battle of law firm resumes as three firms vie for the lead counsel spot to represent investors in a securities class action against an Israeli biotech firm that is...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

IN RE BIOLINERX LTD. SECURITIES LITIGATION

Case Number

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

January 05, 2023

Recent Articles By Aaron

February 13, 2024
Convicted NC Doctor Can't Get Recordings From Prosecutors
February 08, 2024
$490M FCA Verdict Against Medical Distributor Cut In Half
January 12, 2024
Judge Won't Recuse Himself Over Son-In-Law's Job At Firm
December 06, 2023
Spencer Fane Pushes Growth With Snow Christensen Merger
November 15, 2023
Atty For Failed Insurance Co. Wants Out, Says No One Home
November 08, 2023
Acutus Medical's GC Will Exit Amid Reduction In Force
October 19, 2023
Faegre Drinker Adds Attys With Health Care Experience
September 11, 2023
Latham, Quinn Emanuel Pressed For Docs In Antitrust Case
August 25, 2023
9th Circ. Says Non-MDL Clients Can Be Part Of Common Fund
August 10, 2023
Blue Cross Can Subpoena Lab Exec's Atty In Fraud Suit